跳至主要内容
临床试验/NCT03853525
NCT03853525已完成4 期

Safety and Efficacy Evaluation of the Use of Bepantol® Derma Spray After Laser Depilation in the Inguinal Region in Adult Women - 21 Days Use at Home

Bayer1 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2019年2月11日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
Bayer
入组人数
35
试验地点
1
主要终点
Transepidermal water loss by TEWL probe

研究概览

简要总结

In this study, researchers want to learn more about the effect of dexpanthenol dermal spray on skin recovery after a dermatological procedure for hair removal (laser depilation) in the groin and intimate area in adult women.

After the hair removal procedure, participants will return within 3 weeks for 3 visits to the study center to investigate the skin condition such as redness, irritation, softness of skin and possible side effects. Study participants will also be asked about their general acceptance of dexpanthenol dermal spray.

详细描述

The primary objective is to evaluate the efficacy of the test product to aid skin recovery after lasering depilation in the intima and inguinal region.

Secondary objectives comprise clinical efficacy with respect to skin hydration, softness, vitality, appearance etc. and skin recovery, consumer judgement of product performance and acceptability, and safety.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Phototypes I and II according to the Fitzpatrick scale
  • Participants willing to have a dermatological procedure (laser depilation) in the inguinal region to remove hairs in the region

排除标准

  • Pathologies and/or skin injuries, such as psoriasis, sensitive skin, skin cancer, atopic dermatitis or other medical criteria to be considered at the time of evaluation
  • Hyperpigmentations in the test area that interfere with the evaluation of possible reactions (vascular malformations, scars, increase of pilosity and large amount of nevi)
  • Pathologies and/or active skin injuries (local and/or disseminated) in the evaluation area

研究组 & 干预措施

Women_Inguinal side BAY207543

Experimental

Adult women apply BAY207543 randomized to one side of the inguinal region and semisolid vaseline to the other side of the inguinal region after laser depilation. The side with BAY207543 is investigated.

干预措施: BAY207543 (Bepanthol, Bepantol® Derma Spray) (Drug)

Women_Inguinal side BAY207543

Experimental

Adult women apply BAY207543 randomized to one side of the inguinal region and semisolid vaseline to the other side of the inguinal region after laser depilation. The side with BAY207543 is investigated.

干预措施: Semisolid vaseline (Other)

Women_Inguinal side Vaseline

Active Comparator

Adult women apply BAY207543 randomized to one side of the inguinal region and semisolid vaseline to the other side of the inguinal region after laser depilation. The side with vaseline is investigated.

干预措施: BAY207543 (Bepanthol, Bepantol® Derma Spray) (Drug)

Women_Inguinal side Vaseline

Active Comparator

Adult women apply BAY207543 randomized to one side of the inguinal region and semisolid vaseline to the other side of the inguinal region after laser depilation. The side with vaseline is investigated.

干预措施: Semisolid vaseline (Other)

结局指标

主要结局

Transepidermal water loss by TEWL probe

时间窗: Up to 23 days

The transepidermal water loss (TEWL) is measured in g m2 h-1 with a Tewameter TM300.

次要结局

  • Number of adverse events by dermatological evaluation(Up to 23 days)
  • Skin properties of the participants(Up to 23 days)
  • Treatment satisfaction(Up to 23 days)
  • Product evaluation(Up to 23 days)
  • Severity of adverse events by dermatological evaluation(Up to 23 days)

研究者

发起方
Bayer
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

A Study to Gain Information How Well Dexpanthenol... | 临床试验